A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH

Clinical trial NCT04457336 · TERMINATED

Trial details

NCT number: NCT04457336
Sponsor: Spruce Biosciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Congenital Adrenal Hyperplasia

Start date: 2020-08-26
Primary completion: 2024-02-09
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.